Global Favipiravir Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Favipiravir market size was valued at US$ 335.3 million in 2023. With growing demand in downstream market, the Favipiravir is forecast to a readjusted size of US$ 55 million by 2030 with a CAGR of -22.8% during review period.
The research report highlights the growth potential of the global Favipiravir market. Favipiravir are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Favipiravir. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Favipiravir market.
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Key Features:
The report on Favipiravir market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Favipiravir market. It may include historical data, market segmentation by Type (e.g., Brand Drug, Generic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Favipiravir market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Favipiravir market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Favipiravir industry. This include advancements in Favipiravir technology, Favipiravir new entrants, Favipiravir new investment, and other innovations that are shaping the future of Favipiravir.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Favipiravir market. It includes factors influencing customer ' purchasing decisions, preferences for Favipiravir product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Favipiravir market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Favipiravir market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Favipiravir market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Favipiravir industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Favipiravir market.
Market Segmentation:
Favipiravir market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Favipiravir market?
What factors are driving Favipiravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Favipiravir market opportunities vary by end market size?
How does Favipiravir break out type, application?
According to our LPI (LP Information) latest study, the global Favipiravir market size was valued at US$ 335.3 million in 2023. With growing demand in downstream market, the Favipiravir is forecast to a readjusted size of US$ 55 million by 2030 with a CAGR of -22.8% during review period.
The research report highlights the growth potential of the global Favipiravir market. Favipiravir are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Favipiravir. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Favipiravir market.
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Key Features:
The report on Favipiravir market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Favipiravir market. It may include historical data, market segmentation by Type (e.g., Brand Drug, Generic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Favipiravir market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Favipiravir market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Favipiravir industry. This include advancements in Favipiravir technology, Favipiravir new entrants, Favipiravir new investment, and other innovations that are shaping the future of Favipiravir.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Favipiravir market. It includes factors influencing customer ' purchasing decisions, preferences for Favipiravir product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Favipiravir market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Favipiravir market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Favipiravir market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Favipiravir industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Favipiravir market.
Market Segmentation:
Favipiravir market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Brand Drug
- Generic Drug
- Influenza Viruses
- COVID-19
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
- Cipla
- Lupin
- Sun Pharma
- Hisun Pharm
What is the 10-year outlook for the global Favipiravir market?
What factors are driving Favipiravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Favipiravir market opportunities vary by end market size?
How does Favipiravir break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Favipiravir Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Favipiravir by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Favipiravir by Country/Region, 2019, 2023 & 2030
2.2 Favipiravir Segment by Type
2.2.1 Brand Drug
2.2.2 Generic Drug
2.3 Favipiravir Sales by Type
2.3.1 Global Favipiravir Sales Market Share by Type (2019-2024)
2.3.2 Global Favipiravir Revenue and Market Share by Type (2019-2024)
2.3.3 Global Favipiravir Sale Price by Type (2019-2024)
2.4 Favipiravir Segment by Application
2.4.1 Influenza Viruses
2.4.2 COVID-19
2.4.3 Others
2.5 Favipiravir Sales by Application
2.5.1 Global Favipiravir Sale Market Share by Application (2019-2024)
2.5.2 Global Favipiravir Revenue and Market Share by Application (2019-2024)
2.5.3 Global Favipiravir Sale Price by Application (2019-2024)
3 GLOBAL FAVIPIRAVIR BY COMPANY
3.1 Global Favipiravir Breakdown Data by Company
3.1.1 Global Favipiravir Annual Sales by Company (2019-2024)
3.1.2 Global Favipiravir Sales Market Share by Company (2019-2024)
3.2 Global Favipiravir Annual Revenue by Company (2019-2024)
3.2.1 Global Favipiravir Revenue by Company (2019-2024)
3.2.2 Global Favipiravir Revenue Market Share by Company (2019-2024)
3.3 Global Favipiravir Sale Price by Company
3.4 Key Manufacturers Favipiravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir Product Location Distribution
3.4.2 Players Favipiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FAVIPIRAVIR BY GEOGRAPHIC REGION
4.1 World Historic Favipiravir Market Size by Geographic Region (2019-2024)
4.1.1 Global Favipiravir Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Favipiravir Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Favipiravir Market Size by Country/Region (2019-2024)
4.2.1 Global Favipiravir Annual Sales by Country/Region (2019-2024)
4.2.2 Global Favipiravir Annual Revenue by Country/Region (2019-2024)
4.3 Americas Favipiravir Sales Growth
4.4 APAC Favipiravir Sales Growth
4.5 Europe Favipiravir Sales Growth
4.6 Middle East & Africa Favipiravir Sales Growth
5 AMERICAS
5.1 Americas Favipiravir Sales by Country
5.1.1 Americas Favipiravir Sales by Country (2019-2024)
5.1.2 Americas Favipiravir Revenue by Country (2019-2024)
5.2 Americas Favipiravir Sales by Type
5.3 Americas Favipiravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir Sales by Region
6.1.1 APAC Favipiravir Sales by Region (2019-2024)
6.1.2 APAC Favipiravir Revenue by Region (2019-2024)
6.2 APAC Favipiravir Sales by Type
6.3 APAC Favipiravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Favipiravir by Country
7.1.1 Europe Favipiravir Sales by Country (2019-2024)
7.1.2 Europe Favipiravir Revenue by Country (2019-2024)
7.2 Europe Favipiravir Sales by Type
7.3 Europe Favipiravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Favipiravir by Country
8.1.1 Middle East & Africa Favipiravir Sales by Country (2019-2024)
8.1.2 Middle East & Africa Favipiravir Revenue by Country (2019-2024)
8.2 Middle East & Africa Favipiravir Sales by Type
8.3 Middle East & Africa Favipiravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Favipiravir
10.3 Manufacturing Process Analysis of Favipiravir
10.4 Industry Chain Structure of Favipiravir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Favipiravir Distributors
11.3 Favipiravir Customer
12 WORLD FORECAST REVIEW FOR FAVIPIRAVIR BY GEOGRAPHIC REGION
12.1 Global Favipiravir Market Size Forecast by Region
12.1.1 Global Favipiravir Forecast by Region (2025-2030)
12.1.2 Global Favipiravir Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Favipiravir Forecast by Type
12.7 Global Favipiravir Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ChemRar Group
13.1.1 ChemRar Group Company Information
13.1.2 ChemRar Group Favipiravir Product Portfolios and Specifications
13.1.3 ChemRar Group Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 ChemRar Group Main Business Overview
13.1.5 ChemRar Group Latest Developments
13.2 Glenmark
13.2.1 Glenmark Company Information
13.2.2 Glenmark Favipiravir Product Portfolios and Specifications
13.2.3 Glenmark Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Glenmark Main Business Overview
13.2.5 Glenmark Latest Developments
13.3 Fujifilm
13.3.1 Fujifilm Company Information
13.3.2 Fujifilm Favipiravir Product Portfolios and Specifications
13.3.3 Fujifilm Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fujifilm Main Business Overview
13.3.5 Fujifilm Latest Developments
13.4 Dr. Reddy
13.4.1 Dr. Reddy Company Information
13.4.2 Dr. Reddy Favipiravir Product Portfolios and Specifications
13.4.3 Dr. Reddy Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Dr. Reddy Main Business Overview
13.4.5 Dr. Reddy Latest Developments
13.5 R-Pharma
13.5.1 R-Pharma Company Information
13.5.2 R-Pharma Favipiravir Product Portfolios and Specifications
13.5.3 R-Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 R-Pharma Main Business Overview
13.5.5 R-Pharma Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Favipiravir Product Portfolios and Specifications
13.6.3 Cipla Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Favipiravir Product Portfolios and Specifications
13.7.3 Lupin Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Favipiravir Product Portfolios and Specifications
13.8.3 Sun Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Hisun Pharm
13.9.1 Hisun Pharm Company Information
13.9.2 Hisun Pharm Favipiravir Product Portfolios and Specifications
13.9.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hisun Pharm Main Business Overview
13.9.5 Hisun Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Favipiravir Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Favipiravir by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Favipiravir by Country/Region, 2019, 2023 & 2030
2.2 Favipiravir Segment by Type
2.2.1 Brand Drug
2.2.2 Generic Drug
2.3 Favipiravir Sales by Type
2.3.1 Global Favipiravir Sales Market Share by Type (2019-2024)
2.3.2 Global Favipiravir Revenue and Market Share by Type (2019-2024)
2.3.3 Global Favipiravir Sale Price by Type (2019-2024)
2.4 Favipiravir Segment by Application
2.4.1 Influenza Viruses
2.4.2 COVID-19
2.4.3 Others
2.5 Favipiravir Sales by Application
2.5.1 Global Favipiravir Sale Market Share by Application (2019-2024)
2.5.2 Global Favipiravir Revenue and Market Share by Application (2019-2024)
2.5.3 Global Favipiravir Sale Price by Application (2019-2024)
3 GLOBAL FAVIPIRAVIR BY COMPANY
3.1 Global Favipiravir Breakdown Data by Company
3.1.1 Global Favipiravir Annual Sales by Company (2019-2024)
3.1.2 Global Favipiravir Sales Market Share by Company (2019-2024)
3.2 Global Favipiravir Annual Revenue by Company (2019-2024)
3.2.1 Global Favipiravir Revenue by Company (2019-2024)
3.2.2 Global Favipiravir Revenue Market Share by Company (2019-2024)
3.3 Global Favipiravir Sale Price by Company
3.4 Key Manufacturers Favipiravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir Product Location Distribution
3.4.2 Players Favipiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FAVIPIRAVIR BY GEOGRAPHIC REGION
4.1 World Historic Favipiravir Market Size by Geographic Region (2019-2024)
4.1.1 Global Favipiravir Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Favipiravir Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Favipiravir Market Size by Country/Region (2019-2024)
4.2.1 Global Favipiravir Annual Sales by Country/Region (2019-2024)
4.2.2 Global Favipiravir Annual Revenue by Country/Region (2019-2024)
4.3 Americas Favipiravir Sales Growth
4.4 APAC Favipiravir Sales Growth
4.5 Europe Favipiravir Sales Growth
4.6 Middle East & Africa Favipiravir Sales Growth
5 AMERICAS
5.1 Americas Favipiravir Sales by Country
5.1.1 Americas Favipiravir Sales by Country (2019-2024)
5.1.2 Americas Favipiravir Revenue by Country (2019-2024)
5.2 Americas Favipiravir Sales by Type
5.3 Americas Favipiravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir Sales by Region
6.1.1 APAC Favipiravir Sales by Region (2019-2024)
6.1.2 APAC Favipiravir Revenue by Region (2019-2024)
6.2 APAC Favipiravir Sales by Type
6.3 APAC Favipiravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Favipiravir by Country
7.1.1 Europe Favipiravir Sales by Country (2019-2024)
7.1.2 Europe Favipiravir Revenue by Country (2019-2024)
7.2 Europe Favipiravir Sales by Type
7.3 Europe Favipiravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Favipiravir by Country
8.1.1 Middle East & Africa Favipiravir Sales by Country (2019-2024)
8.1.2 Middle East & Africa Favipiravir Revenue by Country (2019-2024)
8.2 Middle East & Africa Favipiravir Sales by Type
8.3 Middle East & Africa Favipiravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Favipiravir
10.3 Manufacturing Process Analysis of Favipiravir
10.4 Industry Chain Structure of Favipiravir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Favipiravir Distributors
11.3 Favipiravir Customer
12 WORLD FORECAST REVIEW FOR FAVIPIRAVIR BY GEOGRAPHIC REGION
12.1 Global Favipiravir Market Size Forecast by Region
12.1.1 Global Favipiravir Forecast by Region (2025-2030)
12.1.2 Global Favipiravir Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Favipiravir Forecast by Type
12.7 Global Favipiravir Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ChemRar Group
13.1.1 ChemRar Group Company Information
13.1.2 ChemRar Group Favipiravir Product Portfolios and Specifications
13.1.3 ChemRar Group Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 ChemRar Group Main Business Overview
13.1.5 ChemRar Group Latest Developments
13.2 Glenmark
13.2.1 Glenmark Company Information
13.2.2 Glenmark Favipiravir Product Portfolios and Specifications
13.2.3 Glenmark Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Glenmark Main Business Overview
13.2.5 Glenmark Latest Developments
13.3 Fujifilm
13.3.1 Fujifilm Company Information
13.3.2 Fujifilm Favipiravir Product Portfolios and Specifications
13.3.3 Fujifilm Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Fujifilm Main Business Overview
13.3.5 Fujifilm Latest Developments
13.4 Dr. Reddy
13.4.1 Dr. Reddy Company Information
13.4.2 Dr. Reddy Favipiravir Product Portfolios and Specifications
13.4.3 Dr. Reddy Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Dr. Reddy Main Business Overview
13.4.5 Dr. Reddy Latest Developments
13.5 R-Pharma
13.5.1 R-Pharma Company Information
13.5.2 R-Pharma Favipiravir Product Portfolios and Specifications
13.5.3 R-Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 R-Pharma Main Business Overview
13.5.5 R-Pharma Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Favipiravir Product Portfolios and Specifications
13.6.3 Cipla Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Favipiravir Product Portfolios and Specifications
13.7.3 Lupin Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Favipiravir Product Portfolios and Specifications
13.8.3 Sun Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Hisun Pharm
13.9.1 Hisun Pharm Company Information
13.9.2 Hisun Pharm Favipiravir Product Portfolios and Specifications
13.9.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hisun Pharm Main Business Overview
13.9.5 Hisun Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Favipiravir Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Favipiravir Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Brand Drug
Table 4. Major Players of Generic Drug
Table 5. Global Favipiravir Sales by Type (2019-2024) & (K Units)
Table 6. Global Favipiravir Sales Market Share by Type (2019-2024)
Table 7. Global Favipiravir Revenue by Type (2019-2024) & ($ million)
Table 8. Global Favipiravir Revenue Market Share by Type (2019-2024)
Table 9. Global Favipiravir Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Favipiravir Sales by Application (2019-2024) & (K Units)
Table 11. Global Favipiravir Sales Market Share by Application (2019-2024)
Table 12. Global Favipiravir Revenue by Application (2019-2024)
Table 13. Global Favipiravir Revenue Market Share by Application (2019-2024)
Table 14. Global Favipiravir Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Favipiravir Sales by Company (2019-2024) & (K Units)
Table 16. Global Favipiravir Sales Market Share by Company (2019-2024)
Table 17. Global Favipiravir Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Favipiravir Revenue Market Share by Company (2019-2024)
Table 19. Global Favipiravir Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Favipiravir Producing Area Distribution and Sales Area
Table 21. Players Favipiravir Products Offered
Table 22. Favipiravir Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Favipiravir Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Favipiravir Sales Market Share Geographic Region (2019-2024)
Table 27. Global Favipiravir Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Favipiravir Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Favipiravir Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Favipiravir Sales Market Share by Country/Region (2019-2024)
Table 31. Global Favipiravir Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Favipiravir Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Favipiravir Sales by Country (2019-2024) & (K Units)
Table 34. Americas Favipiravir Sales Market Share by Country (2019-2024)
Table 35. Americas Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Favipiravir Revenue Market Share by Country (2019-2024)
Table 37. Americas Favipiravir Sales by Type (2019-2024) & (K Units)
Table 38. Americas Favipiravir Sales by Application (2019-2024) & (K Units)
Table 39. APAC Favipiravir Sales by Region (2019-2024) & (K Units)
Table 40. APAC Favipiravir Sales Market Share by Region (2019-2024)
Table 41. APAC Favipiravir Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Favipiravir Revenue Market Share by Region (2019-2024)
Table 43. APAC Favipiravir Sales by Type (2019-2024) & (K Units)
Table 44. APAC Favipiravir Sales by Application (2019-2024) & (K Units)
Table 45. Europe Favipiravir Sales by Country (2019-2024) & (K Units)
Table 46. Europe Favipiravir Sales Market Share by Country (2019-2024)
Table 47. Europe Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Favipiravir Revenue Market Share by Country (2019-2024)
Table 49. Europe Favipiravir Sales by Type (2019-2024) & (K Units)
Table 50. Europe Favipiravir Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Favipiravir Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Favipiravir Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Favipiravir Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Favipiravir Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Favipiravir Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Favipiravir
Table 58. Key Market Challenges & Risks of Favipiravir
Table 59. Key Industry Trends of Favipiravir
Table 60. Favipiravir Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Favipiravir Distributors List
Table 63. Favipiravir Customer List
Table 64. Global Favipiravir Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Favipiravir Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Favipiravir Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Favipiravir Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Favipiravir Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Favipiravir Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Favipiravir Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Favipiravir Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. ChemRar Group Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 79. ChemRar Group Favipiravir Product Portfolios and Specifications
Table 80. ChemRar Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. ChemRar Group Main Business
Table 82. ChemRar Group Latest Developments
Table 83. Glenmark Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 84. Glenmark Favipiravir Product Portfolios and Specifications
Table 85. Glenmark Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Glenmark Main Business
Table 87. Glenmark Latest Developments
Table 88. Fujifilm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 89. Fujifilm Favipiravir Product Portfolios and Specifications
Table 90. Fujifilm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Fujifilm Main Business
Table 92. Fujifilm Latest Developments
Table 93. Dr. Reddy Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy Favipiravir Product Portfolios and Specifications
Table 95. Dr. Reddy Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Dr. Reddy Main Business
Table 97. Dr. Reddy Latest Developments
Table 98. R-Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 99. R-Pharma Favipiravir Product Portfolios and Specifications
Table 100. R-Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. R-Pharma Main Business
Table 102. R-Pharma Latest Developments
Table 103. Cipla Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 104. Cipla Favipiravir Product Portfolios and Specifications
Table 105. Cipla Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Cipla Main Business
Table 107. Cipla Latest Developments
Table 108. Lupin Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 109. Lupin Favipiravir Product Portfolios and Specifications
Table 110. Lupin Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Lupin Main Business
Table 112. Lupin Latest Developments
Table 113. Sun Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 114. Sun Pharma Favipiravir Product Portfolios and Specifications
Table 115. Sun Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sun Pharma Main Business
Table 117. Sun Pharma Latest Developments
Table 118. Hisun Pharm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 119. Hisun Pharm Favipiravir Product Portfolios and Specifications
Table 120. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Hisun Pharm Main Business
Table 122. Hisun Pharm Latest Developments
Table 1. Favipiravir Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Favipiravir Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Brand Drug
Table 4. Major Players of Generic Drug
Table 5. Global Favipiravir Sales by Type (2019-2024) & (K Units)
Table 6. Global Favipiravir Sales Market Share by Type (2019-2024)
Table 7. Global Favipiravir Revenue by Type (2019-2024) & ($ million)
Table 8. Global Favipiravir Revenue Market Share by Type (2019-2024)
Table 9. Global Favipiravir Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Favipiravir Sales by Application (2019-2024) & (K Units)
Table 11. Global Favipiravir Sales Market Share by Application (2019-2024)
Table 12. Global Favipiravir Revenue by Application (2019-2024)
Table 13. Global Favipiravir Revenue Market Share by Application (2019-2024)
Table 14. Global Favipiravir Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Favipiravir Sales by Company (2019-2024) & (K Units)
Table 16. Global Favipiravir Sales Market Share by Company (2019-2024)
Table 17. Global Favipiravir Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Favipiravir Revenue Market Share by Company (2019-2024)
Table 19. Global Favipiravir Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Favipiravir Producing Area Distribution and Sales Area
Table 21. Players Favipiravir Products Offered
Table 22. Favipiravir Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Favipiravir Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Favipiravir Sales Market Share Geographic Region (2019-2024)
Table 27. Global Favipiravir Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Favipiravir Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Favipiravir Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Favipiravir Sales Market Share by Country/Region (2019-2024)
Table 31. Global Favipiravir Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Favipiravir Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Favipiravir Sales by Country (2019-2024) & (K Units)
Table 34. Americas Favipiravir Sales Market Share by Country (2019-2024)
Table 35. Americas Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Favipiravir Revenue Market Share by Country (2019-2024)
Table 37. Americas Favipiravir Sales by Type (2019-2024) & (K Units)
Table 38. Americas Favipiravir Sales by Application (2019-2024) & (K Units)
Table 39. APAC Favipiravir Sales by Region (2019-2024) & (K Units)
Table 40. APAC Favipiravir Sales Market Share by Region (2019-2024)
Table 41. APAC Favipiravir Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Favipiravir Revenue Market Share by Region (2019-2024)
Table 43. APAC Favipiravir Sales by Type (2019-2024) & (K Units)
Table 44. APAC Favipiravir Sales by Application (2019-2024) & (K Units)
Table 45. Europe Favipiravir Sales by Country (2019-2024) & (K Units)
Table 46. Europe Favipiravir Sales Market Share by Country (2019-2024)
Table 47. Europe Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Favipiravir Revenue Market Share by Country (2019-2024)
Table 49. Europe Favipiravir Sales by Type (2019-2024) & (K Units)
Table 50. Europe Favipiravir Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Favipiravir Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Favipiravir Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Favipiravir Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Favipiravir Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Favipiravir Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Favipiravir Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Favipiravir
Table 58. Key Market Challenges & Risks of Favipiravir
Table 59. Key Industry Trends of Favipiravir
Table 60. Favipiravir Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Favipiravir Distributors List
Table 63. Favipiravir Customer List
Table 64. Global Favipiravir Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Favipiravir Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Favipiravir Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Favipiravir Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Favipiravir Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Favipiravir Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Favipiravir Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Favipiravir Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Favipiravir Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Favipiravir Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. ChemRar Group Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 79. ChemRar Group Favipiravir Product Portfolios and Specifications
Table 80. ChemRar Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. ChemRar Group Main Business
Table 82. ChemRar Group Latest Developments
Table 83. Glenmark Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 84. Glenmark Favipiravir Product Portfolios and Specifications
Table 85. Glenmark Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Glenmark Main Business
Table 87. Glenmark Latest Developments
Table 88. Fujifilm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 89. Fujifilm Favipiravir Product Portfolios and Specifications
Table 90. Fujifilm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Fujifilm Main Business
Table 92. Fujifilm Latest Developments
Table 93. Dr. Reddy Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy Favipiravir Product Portfolios and Specifications
Table 95. Dr. Reddy Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Dr. Reddy Main Business
Table 97. Dr. Reddy Latest Developments
Table 98. R-Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 99. R-Pharma Favipiravir Product Portfolios and Specifications
Table 100. R-Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. R-Pharma Main Business
Table 102. R-Pharma Latest Developments
Table 103. Cipla Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 104. Cipla Favipiravir Product Portfolios and Specifications
Table 105. Cipla Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Cipla Main Business
Table 107. Cipla Latest Developments
Table 108. Lupin Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 109. Lupin Favipiravir Product Portfolios and Specifications
Table 110. Lupin Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Lupin Main Business
Table 112. Lupin Latest Developments
Table 113. Sun Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 114. Sun Pharma Favipiravir Product Portfolios and Specifications
Table 115. Sun Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sun Pharma Main Business
Table 117. Sun Pharma Latest Developments
Table 118. Hisun Pharm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 119. Hisun Pharm Favipiravir Product Portfolios and Specifications
Table 120. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Hisun Pharm Main Business
Table 122. Hisun Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Favipiravir
Figure 2. Favipiravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Favipiravir Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Favipiravir Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Brand Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Favipiravir Sales Market Share by Type in 2023
Figure 12. Global Favipiravir Revenue Market Share by Type (2019-2024)
Figure 13. Favipiravir Consumed in Influenza Viruses
Figure 14. Global Favipiravir Market: Influenza Viruses (2019-2024) & (K Units)
Figure 15. Favipiravir Consumed in COVID-19
Figure 16. Global Favipiravir Market: COVID-19 (2019-2024) & (K Units)
Figure 17. Favipiravir Consumed in Others
Figure 18. Global Favipiravir Market: Others (2019-2024) & (K Units)
Figure 19. Global Favipiravir Sales Market Share by Application (2023)
Figure 20. Global Favipiravir Revenue Market Share by Application in 2023
Figure 21. Favipiravir Sales Market by Company in 2023 (K Units)
Figure 22. Global Favipiravir Sales Market Share by Company in 2023
Figure 23. Favipiravir Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Favipiravir Revenue Market Share by Company in 2023
Figure 25. Global Favipiravir Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Favipiravir Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Favipiravir Sales 2019-2024 (K Units)
Figure 28. Americas Favipiravir Revenue 2019-2024 ($ Millions)
Figure 29. APAC Favipiravir Sales 2019-2024 (K Units)
Figure 30. APAC Favipiravir Revenue 2019-2024 ($ Millions)
Figure 31. Europe Favipiravir Sales 2019-2024 (K Units)
Figure 32. Europe Favipiravir Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Favipiravir Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Favipiravir Revenue 2019-2024 ($ Millions)
Figure 35. Americas Favipiravir Sales Market Share by Country in 2023
Figure 36. Americas Favipiravir Revenue Market Share by Country in 2023
Figure 37. Americas Favipiravir Sales Market Share by Type (2019-2024)
Figure 38. Americas Favipiravir Sales Market Share by Application (2019-2024)
Figure 39. United States Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Favipiravir Sales Market Share by Region in 2023
Figure 44. APAC Favipiravir Revenue Market Share by Regions in 2023
Figure 45. APAC Favipiravir Sales Market Share by Type (2019-2024)
Figure 46. APAC Favipiravir Sales Market Share by Application (2019-2024)
Figure 47. China Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Favipiravir Sales Market Share by Country in 2023
Figure 55. Europe Favipiravir Revenue Market Share by Country in 2023
Figure 56. Europe Favipiravir Sales Market Share by Type (2019-2024)
Figure 57. Europe Favipiravir Sales Market Share by Application (2019-2024)
Figure 58. Germany Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Favipiravir Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Favipiravir Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Favipiravir Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Favipiravir Sales Market Share by Application (2019-2024)
Figure 67. Egypt Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Favipiravir in 2023
Figure 73. Manufacturing Process Analysis of Favipiravir
Figure 74. Industry Chain Structure of Favipiravir
Figure 75. Channels of Distribution
Figure 76. Global Favipiravir Sales Market Forecast by Region (2025-2030)
Figure 77. Global Favipiravir Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Favipiravir Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Favipiravir Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Favipiravir Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Favipiravir Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Favipiravir
Figure 2. Favipiravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Favipiravir Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Favipiravir Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Brand Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Favipiravir Sales Market Share by Type in 2023
Figure 12. Global Favipiravir Revenue Market Share by Type (2019-2024)
Figure 13. Favipiravir Consumed in Influenza Viruses
Figure 14. Global Favipiravir Market: Influenza Viruses (2019-2024) & (K Units)
Figure 15. Favipiravir Consumed in COVID-19
Figure 16. Global Favipiravir Market: COVID-19 (2019-2024) & (K Units)
Figure 17. Favipiravir Consumed in Others
Figure 18. Global Favipiravir Market: Others (2019-2024) & (K Units)
Figure 19. Global Favipiravir Sales Market Share by Application (2023)
Figure 20. Global Favipiravir Revenue Market Share by Application in 2023
Figure 21. Favipiravir Sales Market by Company in 2023 (K Units)
Figure 22. Global Favipiravir Sales Market Share by Company in 2023
Figure 23. Favipiravir Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Favipiravir Revenue Market Share by Company in 2023
Figure 25. Global Favipiravir Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Favipiravir Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Favipiravir Sales 2019-2024 (K Units)
Figure 28. Americas Favipiravir Revenue 2019-2024 ($ Millions)
Figure 29. APAC Favipiravir Sales 2019-2024 (K Units)
Figure 30. APAC Favipiravir Revenue 2019-2024 ($ Millions)
Figure 31. Europe Favipiravir Sales 2019-2024 (K Units)
Figure 32. Europe Favipiravir Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Favipiravir Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Favipiravir Revenue 2019-2024 ($ Millions)
Figure 35. Americas Favipiravir Sales Market Share by Country in 2023
Figure 36. Americas Favipiravir Revenue Market Share by Country in 2023
Figure 37. Americas Favipiravir Sales Market Share by Type (2019-2024)
Figure 38. Americas Favipiravir Sales Market Share by Application (2019-2024)
Figure 39. United States Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Favipiravir Sales Market Share by Region in 2023
Figure 44. APAC Favipiravir Revenue Market Share by Regions in 2023
Figure 45. APAC Favipiravir Sales Market Share by Type (2019-2024)
Figure 46. APAC Favipiravir Sales Market Share by Application (2019-2024)
Figure 47. China Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Favipiravir Sales Market Share by Country in 2023
Figure 55. Europe Favipiravir Revenue Market Share by Country in 2023
Figure 56. Europe Favipiravir Sales Market Share by Type (2019-2024)
Figure 57. Europe Favipiravir Sales Market Share by Application (2019-2024)
Figure 58. Germany Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Favipiravir Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Favipiravir Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Favipiravir Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Favipiravir Sales Market Share by Application (2019-2024)
Figure 67. Egypt Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Favipiravir Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Favipiravir in 2023
Figure 73. Manufacturing Process Analysis of Favipiravir
Figure 74. Industry Chain Structure of Favipiravir
Figure 75. Channels of Distribution
Figure 76. Global Favipiravir Sales Market Forecast by Region (2025-2030)
Figure 77. Global Favipiravir Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Favipiravir Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Favipiravir Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Favipiravir Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Favipiravir Revenue Market Share Forecast by Application (2025-2030)
